{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:07:17Z","timestamp":1790690837617,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["10208"],"award-info":[{"award-number":["10208"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["2016-72170683"],"award-info":[{"award-number":["2016-72170683"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bneo.2026.100261","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:23:05Z","timestamp":1782382985000},"page":"100261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR\/Cas gene-edited human DLBCL cell models"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7015-9751","authenticated-orcid":false,"given":"Janneke A.","family":"Eken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4653-1952","authenticated-orcid":false,"given":"Fleur R. M.","family":"Havenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben A. L.","family":"de Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Quinten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-3609","authenticated-orcid":false,"given":"Julieta H.","family":"Sep\u00falveda-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans G.","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-6256","authenticated-orcid":false,"given":"Joost S. P.","family":"Vermaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-4517","authenticated-orcid":false,"given":"Cornelis A. M.","family":"van Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-3125","authenticated-orcid":false,"given":"Hendrik","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bneo.2026.100261_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bneo.2026.100261_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ajh.26151","article-title":"2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya","year":"2021","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.bneo.2026.100261_bib3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"6769","key":"10.1016\/j.bneo.2026.100261_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bneo.2026.100261_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.bneo.2026.100261_bib6","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bneo.2026.100261_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.bneo.2026.100261_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1016\/j.bneo.2026.100261_bib9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bneo.2026.100261_bib10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bneo.2026.100261_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bjh.17765","article-title":"Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort","volume":"195","author":"Mishina","year":"2021","journal-title":"Br J Haematol"},{"issue":"18","key":"10.1016\/j.bneo.2026.100261_bib12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2024025652","article-title":"DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma","volume":"145","author":"Chapuy","year":"2025","journal-title":"Blood"},{"issue":"7277","key":"10.1016\/j.bneo.2026.100261_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.bneo.2026.100261_bib14","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.bneo.2026.100261_bib15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230941","article-title":"Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL","volume":"221","author":"Eken","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.bneo.2026.100261_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15746","article-title":"Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia","volume":"8","author":"Minici","year":"2017","journal-title":"Nat Commun"},{"issue":"7718","key":"10.1016\/j.bneo.2026.100261_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"issue":"7247","key":"10.1016\/j.bneo.2026.100261_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bneo.2026.100261_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"issue":"5870","key":"10.1016\/j.bneo.2026.100261_bib20","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bneo.2026.100261_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/MMBR.65.3.371-389.2001","article-title":"Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins","volume":"65","author":"Overbaugh","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"7415","key":"10.1016\/j.bneo.2026.100261_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"D\u00fchren-von Minden","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bneo.2026.100261_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/104303403322167993","article-title":"Retroviral vectors for high-level transgene expression in T lymphocytes","volume":"14","author":"Engels","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.bneo.2026.100261_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J Immunol Methods"},{"issue":"6","key":"10.1016\/j.bneo.2026.100261_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","article-title":"MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo","volume":"22","author":"Fontan","year":"2012","journal-title":"Cancer cell"},{"issue":"6","key":"10.1016\/j.bneo.2026.100261_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.bneo.2026.100261_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00373.x","article-title":"A library of gene expression signatures to illuminate normal and pathological lymphoid biology","volume":"210","author":"Shaffer","year":"2006","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.bneo.2026.100261_bib28","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1038\/s41598-019-44491-x","article-title":"The LL-100 panel: 100 cell lines for blood cancer studies","volume":"9","author":"Quentmeier","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.bneo.2026.100261_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molonc.2008.07.003","article-title":"The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia","volume":"2","author":"Hantschel","year":"2008","journal-title":"Mol Oncol"},{"issue":"6","key":"10.1016\/j.bneo.2026.100261_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.bneo.2026.100261_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.bneo.2026.100261_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.18.02403","article-title":"Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non-germinal center B-cell diffuse large B-cell lymphoma","volume":"37","author":"Younes","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bneo.2026.100261_bib33","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1084\/jem.20180230","article-title":"Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation","volume":"215","author":"Wray-Dutra","year":"2018","journal-title":"J Exp Med"},{"issue":"7657","key":"10.1016\/j.bneo.2026.100261_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature22353","article-title":"The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3\u03b2 inhibition","volume":"546","author":"Varano","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bneo.2026.100261_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"Kuppers","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2026.100261_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bneo.2026.100261_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bneo.2026.100261_bib38","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2016-10-747303","article-title":"Tonic B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"130","author":"Havranek","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2026.100261_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imr.12792","article-title":"Pathogenic B-cell receptor signaling in lymphoid malignancies: new insights to improve treatment","volume":"291","author":"Young","year":"2019","journal-title":"Immunol Rev"},{"issue":"45","key":"10.1016\/j.bneo.2026.100261_bib40","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1038\/s41388-021-02025-8","article-title":"Calcium-dependent signalling in B-cell lymphomas","volume":"40","author":"Berditchevski","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bneo.2026.100261_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrc.2017.111","article-title":"Autoimmunity checkpoints as therapeutic targets in B cell malignancies","volume":"18","author":"M\u00fcschen","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.bneo.2026.100261_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41577-019-0154-3","article-title":"Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation","volume":"19","author":"M\u00fcschen","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"10.1016\/j.bneo.2026.100261_bib43","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood.2023020211","article-title":"CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma","volume":"142","author":"Decombis","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bneo.2026.100261_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.09.004","article-title":"Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: the randomized GUIDANCE-01 trial","volume":"41","author":"Zhang","year":"2023","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.bneo.2026.100261_bib45","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.1913810117","article-title":"IGLV3-21\u221701 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling","volume":"117","author":"Maity","year":"2020","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:18:01Z","timestamp":1790687881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950328026000725"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100261","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR\/Cas gene-edited human DLBCL cell models","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100261"}}